Kiora Pharmaceuticals

Yahoo Finance • 2 years ago

Kiora’s stock rallies as eye drop treatment moves into mid-stage clinical trial

MARKET PULSE Shares of Kiora Pharmaceuticals Inc. (KPRX) soared about 57% in premarket trading on Tuesday after the company said it will begin a Phase 2 clinical trial for its experimental eye drops as a treatment for ocular rheumatoid art... Full story